|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/705 | |
| A61K 38/17 |
| (11) | Patento numeris | 3077415 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14830734.1 |
| Europos patento paraiškos padavimo data | 2014-12-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-10-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2014/051067 |
| Data | 2014-12-07 |
| (87) | Numeris | WO 2015/083173 |
| Data | 2015-06-11 |
| (30) | Numeris | Data | Šalis |
| 201361912631 P | 2013-12-06 | US | |
| 201461924869 P | 2014-01-08 | US |
| (72) |
KAEMPFER, Raymond, IL
SHIRVAN, Anat, IL
ARAD, Gila, IL
|
| (73) |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.,
Hi Tech Park Edmond Safra Campus Givat-Ram, 9139002 Jerusalem,
IL
Atox Bio Ltd., 3 Golda Meir Street Weizmann Science Park, 74036 Ness Ziona, IL |
| (54) | REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28 |
| REDUCTION OF INFLAMMATORY DISEASE SYMPTOMS BY SHORT PEPTIDES THAT INHIBIT SIGNALING THROUGH CD28 |